74 related articles for article (PubMed ID: 3986794)
1. Purine enzymology of human colon carcinomas.
Natsumeda Y; Lui MS; Emrani J; Faderan MA; Reardon MA; Eble JN; Glover JL; Weber G
Cancer Res; 1985 Jun; 45(6):2556-9. PubMed ID: 3986794
[TBL] [Abstract][Full Text] [Related]
2. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
[TBL] [Abstract][Full Text] [Related]
3. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
Natsumeda Y; Ikegami T; Olah E; Weber G
Cancer Res; 1989 Jan; 49(1):88-92. PubMed ID: 2461800
[TBL] [Abstract][Full Text] [Related]
4. Salvage capacity of hepatoma 3924A and action of dipyridamole.
Weber G; Lui MS; Natsumeda Y; Faderan MA
Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma.
Sanfilippo O; Camici M; Tozzi MG; Turriani M; Faranda A; Ipata PL; Silvestrini R
Cancer Biochem Biophys; 1994 Apr; 14(1):57-66. PubMed ID: 7796389
[TBL] [Abstract][Full Text] [Related]
6. Purine salvage enzyme activities in normal and neoplastic human tissues.
Camici M; Tozzi MG; Allegrini S; Del Corso A; Sanfilippo O; Daidone MG; De Marco C; Ipata PL
Cancer Biochem Biophys; 1990 Jul; 11(3):201-9. PubMed ID: 2125239
[TBL] [Abstract][Full Text] [Related]
7. Purine metabolism of human glioblastoma in vivo.
Pillwein K; Chiba P; Knoflach A; Czermak B; Schuchter K; Gersdorf E; Ausserer B; Murr C; Goebl R; Stockhammer G
Cancer Res; 1990 Mar; 50(5):1576-9. PubMed ID: 2154328
[TBL] [Abstract][Full Text] [Related]
8. De novo purine nucleotide synthesis in the rat small and large intestine: effect of dietary protein and purines.
LeLeiko NS; Bronstein AD; Baliga BS; Munro HN
J Pediatr Gastroenterol Nutr; 1983 May; 2(2):313-9. PubMed ID: 6192234
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of novel N-1-sulfonylpyrimidine derivatives on human colon carcinoma cells.
Glavas-Obrovac L; Karner I; Stefanić M; Kasnar-Samprec J; Zinić B
Farmaco; 2005; 60(6-7):479-83. PubMed ID: 15913614
[TBL] [Abstract][Full Text] [Related]
10. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
[TBL] [Abstract][Full Text] [Related]
11. Proliferation-linked increase in phosphoribosylformylglycinamidine synthetase activity (EC 6.3.5.3).
Elliott WL; Weber G
Cancer Res; 1984 Jun; 44(6):2430-4. PubMed ID: 6722784
[TBL] [Abstract][Full Text] [Related]
12. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
Sebolt JS; Aoki T; Eble JN; Glover JL; Weber G
Biochem Pharmacol; 1985 Jan; 34(1):97-100. PubMed ID: 3966920
[TBL] [Abstract][Full Text] [Related]
13. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion.
Reddy BS; Simi B; Patel N; Aliaga C; Rao CV
Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306
[TBL] [Abstract][Full Text] [Related]
14. Enzymology of pyrimidine and carbohydrate metabolism in human colon carcinomas.
Denton JE; Lui MS; Aoki T; Sebolt J; Takeda E; Eble JN; Glover JL; Weber G
Cancer Res; 1982 Mar; 42(3):1176-83. PubMed ID: 7059974
[No Abstract] [Full Text] [Related]
15. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
[TBL] [Abstract][Full Text] [Related]
16. Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells.
Mazurek S; Grimm H; Oehmke M; Weisse G; Teigelkamp S; Eigenbrodt E
Anticancer Res; 2000; 20(6D):5151-4. PubMed ID: 11326687
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
Fischer PH; Pamukcu R; Bittner G; Willson JK
Cancer Res; 1984 Aug; 44(8):3355-9. PubMed ID: 6744269
[TBL] [Abstract][Full Text] [Related]
18. Expression of the glutathione enzyme system of human colon mucosa by localisation, gender and age.
Hoensch H; Peters WH; Roelofs HM; Kirch W
Curr Med Res Opin; 2006 Jun; 22(6):1075-83. PubMed ID: 16846540
[TBL] [Abstract][Full Text] [Related]
19. Targeted and non-targeted actions of anti-cancer drugs.
Weber G; Prajda N
Adv Enzyme Regul; 1994; 34():71-89. PubMed ID: 7942286
[TBL] [Abstract][Full Text] [Related]
20. Development of a bacterial screen for novel hypoxanthine-guanine phosphoribosyltransferase substrates.
Shivashankar K; Subbayya IN; Balaram H
J Mol Microbiol Biotechnol; 2001 Oct; 3(4):557-62. PubMed ID: 11545274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
